Androgen receptor signaling contributes to targeted therapy resistance in melanoma: Inhibiting androgen receptor improved treatment response in preclinical study
Androgen receptor (AR) signaling affects response to BRAF/MEK inhibitor therapy in both males and females with melanoma, researchers from The University of Texas MD Anderson Cancer Center showed in a…